This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangxi Caishi Pharmaceutical Technology Co., Ltd.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Xiaojian Xue: Innovator in Antiviral Drug Development
Introduction
Xiaojian Xue is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral drugs. His innovative work focuses on addressing viral infections, which are a major public health concern.
Latest Patents
Xiaojian Xue holds a patent for a pyridone derivative, which is a novel compound with potential applications as an antiviral drug. The patent details the use of this compound in preventing or treating diseases such as influenza type A and B viral infections. The pyridone derivative exhibits significant activity in inhibiting influenza endonuclease and influenza DNA. This compound can be used alone or in combination with other antiviral agents, significantly shortening the duration of influenza infections and reducing mortality rates. The clinical application prospects for this invention are promising.
Career Highlights
Xiaojian Xue is associated with Jiangxi Caishi Pharmaceutical Technology Co., Ltd., where he continues to advance his research in antiviral drug development. His work has garnered attention for its potential impact on public health, particularly in combating influenza viruses.
Collaborations
Xiaojian collaborates with notable colleagues, including Li Chen and Qing Shao, who contribute to his research efforts in the pharmaceutical field.
Conclusion
Xiaojian Xue's innovative contributions to antiviral drug development highlight his role as a key inventor in the field of medicinal chemistry. His work not only addresses critical health challenges but also paves the way for future advancements in antiviral therapies.